Market Data 
Markets
Join thousands of traders sharing insights, catalysts, and charts.
Good Morning $AVAI 🍳
Good Morning $AVAI
$AVAI - Avant Technologies Creating New Company for Expansion of Diabetes Program
https://marketwirenews.com/news-releases/avant-technologies-creating-new-company-for-expansio-8368341234318225.html
Avant Technologies (OTCQB: AVAI) and Ainnova Tech Bolster FDA Clinical Trial Strategy and Global Reach for Vision AI Platform
FDA Clinical Trial Progress Accelerates with Enhanced Recruitment: On August 12, 2025, Avant Technologies and Ainnova Tech announced a refined patient recruitment strategy for their Vision AI platform's U.S. clinical trial, targeting 1,000 multiethnic diabetic patients across 8-10 sites in community clinics.
✅ Avant Technologies (OTCQB: $AVAI): A Rising Star in AI-Driven Healthcare Innovation
Clinical Protocol Advanced Post-FDA Feedback: July 29, 2025, marked a key milestone as Ainnova revised its clinical trial protocol based on FDA input from a mid-July meeting, with resubmission imminent.
Good Morning $AVAI
Good Morning $AVAI
$AVAI News:
$AVAI - Avant Technologies Creating New Company for Expansion of Diabetes Program
Avant Technologies Creating New Company for Expansion of Diabetes Program PR Newswire LAS VEGAS , June 24, 2025
💪 $AVAI a Vision for the Future 💪
Avant’s proactive approach—combining AI-driven diagnostics with biotech-driven treatments—sets it apart in the healthcare technology space. The new company will streamline efforts to innovate and commercialize solutions, building on Avant’s existing partnerships with industry leaders like Roche and Apollo Hospitals. By addressing both prevention and treatment, Avant is poised to become a key player in global diabetes care.
🚀 The Bottom Line 🚀
Avant Technologies (OTCQB: $AVAI) is making bold moves to redefine diabetes management, from early detection with Vision AI to potential treatments through its new company. With a scalable platform, strategic partnerships, and a clear vision for growth, AVAI is an under-the-radar stock with breakout potential. Investors looking for exposure to AI and biotech innovation should keep AVAI on their radar.
This merger makes sense. $AVAI
|
Followers
|
23
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1681
|
|
Created
|
02/08/21
|
Type
|
Free
|
| Moderators | |||
Globex Mining Enterprises (USOTC:GLBXF) has announced it has signed an option agreement with private company 1001565486 Ontario Inc. covering Globex’s RAMP/Maude Lake gold property in northeastern Ontario, southeast of the Timmins mining district. Under the terms of the agreement outlined in a media release, Ontario Inc. may earn a 100 per cent interest in the property through a combination […]
AI
